CAS NO: | 1480724-61-5 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | Vosoritide (BMN 111) is a modified recombinant CNP (C-type natriuretic peptide) analogue, binds toNPR-B(natriuretic peptide receptor type B) and reduces the activity ofFGFR3(fibroblast growth factorreceptor 3). Vosoritide can be used in achondroplasia and dwarfism research[1][2][3]. | ||||||||||||||||
体外研究 (In Vitro) | Vosoritide (0.1 μM; 1 h) decreases NPR2 phosphorylation in chondrocytes[2]. Western Blot Analysis[2]
Western Blot Analysis[3]
| ||||||||||||||||
体内研究 (In Vivo) | Vosoritide (subcutaneous injection; 800 μg/kg; once daily; 20 d) treatment leads to improvement in skeletal parameters in Fgfr3 gain-of-function mutation mouse[3].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 4102.73 | ||||||||||||||||
Formula | C176H290N56O51S3 | ||||||||||||||||
CAS 号 | 1480724-61-5 | ||||||||||||||||
Sequence | Pro-Gly-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide bridge:Cys23-Cys39) | ||||||||||||||||
Sequence Shortening | PGQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge:Cys23-Cys39) | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |